nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Vincristine—sarcoma	0.218	0.271	CbGbCtD
Gadoxetate—ABCC3—Etoposide—sarcoma	0.2	0.248	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—sarcoma	0.136	0.169	CbGbCtD
Gadoxetate—ABCC2—Vincristine—sarcoma	0.0992	0.123	CbGbCtD
Gadoxetate—ABCC2—Etoposide—sarcoma	0.0909	0.113	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—sarcoma	0.062	0.0768	CbGbCtD
Gadoxetate—Constipation—Thiotepa—sarcoma	0.000376	0.00194	CcSEcCtD
Gadoxetate—Back pain—Etoposide—sarcoma	0.000374	0.00193	CcSEcCtD
Gadoxetate—Shock—Mitoxantrone—sarcoma	0.000374	0.00193	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Epirubicin—sarcoma	0.000372	0.00192	CcSEcCtD
Gadoxetate—Anorexia—Vincristine—sarcoma	0.000372	0.00192	CcSEcCtD
Gadoxetate—Tachycardia—Mitoxantrone—sarcoma	0.000371	0.00191	CcSEcCtD
Gadoxetate—Skin disorder—Mitoxantrone—sarcoma	0.000369	0.00191	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Epirubicin—sarcoma	0.000368	0.0019	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Doxorubicin—sarcoma	0.000368	0.0019	CcSEcCtD
Gadoxetate—Hyperhidrosis—Mitoxantrone—sarcoma	0.000367	0.0019	CcSEcCtD
Gadoxetate—Hypotension—Vincristine—sarcoma	0.000364	0.00188	CcSEcCtD
Gadoxetate—Feeling abnormal—Thiotepa—sarcoma	0.000362	0.00187	CcSEcCtD
Gadoxetate—Anorexia—Mitoxantrone—sarcoma	0.000362	0.00187	CcSEcCtD
Gadoxetate—Renal failure acute—Doxorubicin—sarcoma	0.000361	0.00187	CcSEcCtD
Gadoxetate—Feeling abnormal—Dactinomycin—sarcoma	0.00036	0.00186	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Thiotepa—sarcoma	0.00036	0.00186	CcSEcCtD
Gadoxetate—Ill-defined disorder—Etoposide—sarcoma	0.000359	0.00186	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dactinomycin—sarcoma	0.000357	0.00184	CcSEcCtD
Gadoxetate—Hypotension—Mitoxantrone—sarcoma	0.000355	0.00183	CcSEcCtD
Gadoxetate—Renal impairment—Doxorubicin—sarcoma	0.00035	0.00181	CcSEcCtD
Gadoxetate—Paraesthesia—Vincristine—sarcoma	0.00035	0.00181	CcSEcCtD
Gadoxetate—Urticaria—Thiotepa—sarcoma	0.000349	0.0018	CcSEcCtD
Gadoxetate—Malaise—Etoposide—sarcoma	0.000349	0.0018	CcSEcCtD
Gadoxetate—Face oedema—Epirubicin—sarcoma	0.000348	0.0018	CcSEcCtD
Gadoxetate—Vertigo—Etoposide—sarcoma	0.000348	0.0018	CcSEcCtD
Gadoxetate—Abdominal pain—Thiotepa—sarcoma	0.000348	0.0018	CcSEcCtD
Gadoxetate—Body temperature increased—Thiotepa—sarcoma	0.000348	0.0018	CcSEcCtD
Gadoxetate—Body temperature increased—Dactinomycin—sarcoma	0.000345	0.00178	CcSEcCtD
Gadoxetate—Abdominal pain—Dactinomycin—sarcoma	0.000345	0.00178	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000344	0.00178	CcSEcCtD
Gadoxetate—Paraesthesia—Mitoxantrone—sarcoma	0.000341	0.00176	CcSEcCtD
Gadoxetate—Loss of consciousness—Etoposide—sarcoma	0.00034	0.00176	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Doxorubicin—sarcoma	0.00034	0.00176	CcSEcCtD
Gadoxetate—Decreased appetite—Vincristine—sarcoma	0.000339	0.00175	CcSEcCtD
Gadoxetate—Dyspnoea—Mitoxantrone—sarcoma	0.000339	0.00175	CcSEcCtD
Gadoxetate—Cough—Etoposide—sarcoma	0.000338	0.00174	CcSEcCtD
Gadoxetate—Blood creatinine increased—Epirubicin—sarcoma	0.000338	0.00174	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Vincristine—sarcoma	0.000337	0.00174	CcSEcCtD
Gadoxetate—Fatigue—Vincristine—sarcoma	0.000336	0.00174	CcSEcCtD
Gadoxetate—Convulsion—Etoposide—sarcoma	0.000335	0.00173	CcSEcCtD
Gadoxetate—Dehydration—Epirubicin—sarcoma	0.000335	0.00173	CcSEcCtD
Gadoxetate—Constipation—Vincristine—sarcoma	0.000333	0.00172	CcSEcCtD
Gadoxetate—Decreased appetite—Mitoxantrone—sarcoma	0.00033	0.00171	CcSEcCtD
Gadoxetate—Chest pain—Etoposide—sarcoma	0.00033	0.0017	CcSEcCtD
Gadoxetate—Hypokalaemia—Epirubicin—sarcoma	0.000328	0.00169	CcSEcCtD
Gadoxetate—Fatigue—Mitoxantrone—sarcoma	0.000327	0.00169	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000327	0.00169	CcSEcCtD
Gadoxetate—Discomfort—Etoposide—sarcoma	0.000326	0.00168	CcSEcCtD
Gadoxetate—Constipation—Mitoxantrone—sarcoma	0.000325	0.00168	CcSEcCtD
Gadoxetate—Hypersensitivity—Thiotepa—sarcoma	0.000324	0.00167	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—sarcoma	0.000322	0.00166	CcSEcCtD
Gadoxetate—Hypersensitivity—Dactinomycin—sarcoma	0.000322	0.00166	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Vincristine—sarcoma	0.000319	0.00165	CcSEcCtD
Gadoxetate—Anaphylactic shock—Etoposide—sarcoma	0.000316	0.00163	CcSEcCtD
Gadoxetate—Asthenia—Thiotepa—sarcoma	0.000316	0.00163	CcSEcCtD
Gadoxetate—Infection—Etoposide—sarcoma	0.000314	0.00162	CcSEcCtD
Gadoxetate—Abdominal distension—Epirubicin—sarcoma	0.000313	0.00162	CcSEcCtD
Gadoxetate—Asthenia—Dactinomycin—sarcoma	0.000313	0.00162	CcSEcCtD
Gadoxetate—Feeling abnormal—Mitoxantrone—sarcoma	0.000313	0.00162	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—sarcoma	0.000312	0.00161	CcSEcCtD
Gadoxetate—Dysphagia—Epirubicin—sarcoma	0.000311	0.00161	CcSEcCtD
Gadoxetate—Pruritus—Thiotepa—sarcoma	0.000311	0.00161	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000311	0.0016	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—sarcoma	0.00031	0.0016	CcSEcCtD
Gadoxetate—Tachycardia—Etoposide—sarcoma	0.000308	0.00159	CcSEcCtD
Gadoxetate—Abdominal pain—Vincristine—sarcoma	0.000308	0.00159	CcSEcCtD
Gadoxetate—Body temperature increased—Vincristine—sarcoma	0.000308	0.00159	CcSEcCtD
Gadoxetate—Skin disorder—Etoposide—sarcoma	0.000307	0.00159	CcSEcCtD
Gadoxetate—Hyperhidrosis—Etoposide—sarcoma	0.000305	0.00158	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—sarcoma	0.000303	0.00157	CcSEcCtD
Gadoxetate—Urticaria—Mitoxantrone—sarcoma	0.000302	0.00156	CcSEcCtD
Gadoxetate—Anorexia—Etoposide—sarcoma	0.000301	0.00156	CcSEcCtD
Gadoxetate—Diarrhoea—Thiotepa—sarcoma	0.000301	0.00155	CcSEcCtD
Gadoxetate—Body temperature increased—Mitoxantrone—sarcoma	0.0003	0.00155	CcSEcCtD
Gadoxetate—Abdominal pain—Mitoxantrone—sarcoma	0.0003	0.00155	CcSEcCtD
Gadoxetate—Bronchitis—Epirubicin—sarcoma	0.000299	0.00155	CcSEcCtD
Gadoxetate—Diarrhoea—Dactinomycin—sarcoma	0.000299	0.00154	CcSEcCtD
Gadoxetate—Hypotension—Etoposide—sarcoma	0.000295	0.00152	CcSEcCtD
Gadoxetate—Dizziness—Thiotepa—sarcoma	0.000291	0.0015	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—sarcoma	0.00029	0.0015	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—sarcoma	0.000288	0.00149	CcSEcCtD
Gadoxetate—Hypersensitivity—Vincristine—sarcoma	0.000287	0.00148	CcSEcCtD
Gadoxetate—Paraesthesia—Etoposide—sarcoma	0.000284	0.00147	CcSEcCtD
Gadoxetate—Dyspnoea—Etoposide—sarcoma	0.000282	0.00145	CcSEcCtD
Gadoxetate—Hypersensitivity—Mitoxantrone—sarcoma	0.00028	0.00145	CcSEcCtD
Gadoxetate—Asthenia—Vincristine—sarcoma	0.00028	0.00145	CcSEcCtD
Gadoxetate—Vomiting—Thiotepa—sarcoma	0.00028	0.00144	CcSEcCtD
Gadoxetate—Vomiting—Dactinomycin—sarcoma	0.000278	0.00143	CcSEcCtD
Gadoxetate—Rash—Thiotepa—sarcoma	0.000277	0.00143	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—sarcoma	0.000277	0.00143	CcSEcCtD
Gadoxetate—Dermatitis—Thiotepa—sarcoma	0.000277	0.00143	CcSEcCtD
Gadoxetate—Headache—Thiotepa—sarcoma	0.000275	0.00142	CcSEcCtD
Gadoxetate—Rash—Dactinomycin—sarcoma	0.000275	0.00142	CcSEcCtD
Gadoxetate—Decreased appetite—Etoposide—sarcoma	0.000275	0.00142	CcSEcCtD
Gadoxetate—Renal failure—Epirubicin—sarcoma	0.000273	0.00141	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Etoposide—sarcoma	0.000273	0.00141	CcSEcCtD
Gadoxetate—Asthenia—Mitoxantrone—sarcoma	0.000272	0.00141	CcSEcCtD
Gadoxetate—Fatigue—Etoposide—sarcoma	0.000272	0.00141	CcSEcCtD
Gadoxetate—Constipation—Etoposide—sarcoma	0.00027	0.0014	CcSEcCtD
Gadoxetate—Conjunctivitis—Epirubicin—sarcoma	0.00027	0.00139	CcSEcCtD
Gadoxetate—Diarrhoea—Vincristine—sarcoma	0.000267	0.00138	CcSEcCtD
Gadoxetate—Nausea—Thiotepa—sarcoma	0.000261	0.00135	CcSEcCtD
Gadoxetate—Feeling abnormal—Etoposide—sarcoma	0.00026	0.00134	CcSEcCtD
Gadoxetate—Diarrhoea—Mitoxantrone—sarcoma	0.00026	0.00134	CcSEcCtD
Gadoxetate—Nausea—Dactinomycin—sarcoma	0.000259	0.00134	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Etoposide—sarcoma	0.000258	0.00133	CcSEcCtD
Gadoxetate—Dizziness—Vincristine—sarcoma	0.000258	0.00133	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—sarcoma	0.000253	0.0013	CcSEcCtD
Gadoxetate—Urticaria—Etoposide—sarcoma	0.000251	0.0013	CcSEcCtD
Gadoxetate—Rhinitis—Epirubicin—sarcoma	0.00025	0.00129	CcSEcCtD
Gadoxetate—Abdominal pain—Etoposide—sarcoma	0.00025	0.00129	CcSEcCtD
Gadoxetate—Body temperature increased—Etoposide—sarcoma	0.00025	0.00129	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—sarcoma	0.00025	0.00129	CcSEcCtD
Gadoxetate—Hypoaesthesia—Epirubicin—sarcoma	0.000248	0.00128	CcSEcCtD
Gadoxetate—Vomiting—Vincristine—sarcoma	0.000248	0.00128	CcSEcCtD
Gadoxetate—Rash—Vincristine—sarcoma	0.000246	0.00127	CcSEcCtD
Gadoxetate—Dermatitis—Vincristine—sarcoma	0.000246	0.00127	CcSEcCtD
Gadoxetate—Connective tissue disorder—Epirubicin—sarcoma	0.000245	0.00127	CcSEcCtD
Gadoxetate—Headache—Vincristine—sarcoma	0.000244	0.00126	CcSEcCtD
Gadoxetate—Vomiting—Mitoxantrone—sarcoma	0.000241	0.00125	CcSEcCtD
Gadoxetate—Rash—Mitoxantrone—sarcoma	0.000239	0.00124	CcSEcCtD
Gadoxetate—Dermatitis—Mitoxantrone—sarcoma	0.000239	0.00124	CcSEcCtD
Gadoxetate—Headache—Mitoxantrone—sarcoma	0.000238	0.00123	CcSEcCtD
Gadoxetate—Hypersensitivity—Etoposide—sarcoma	0.000233	0.0012	CcSEcCtD
Gadoxetate—Nausea—Vincristine—sarcoma	0.000232	0.0012	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—sarcoma	0.000231	0.00119	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—sarcoma	0.000231	0.00119	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—sarcoma	0.000231	0.00119	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—sarcoma	0.000229	0.00119	CcSEcCtD
Gadoxetate—Asthenia—Etoposide—sarcoma	0.000227	0.00117	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—sarcoma	0.000227	0.00117	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—sarcoma	0.000226	0.00117	CcSEcCtD
Gadoxetate—Nausea—Mitoxantrone—sarcoma	0.000226	0.00117	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—sarcoma	0.000225	0.00116	CcSEcCtD
Gadoxetate—Mediastinal disorder—Epirubicin—sarcoma	0.000225	0.00116	CcSEcCtD
Gadoxetate—Chills—Epirubicin—sarcoma	0.000224	0.00116	CcSEcCtD
Gadoxetate—Pruritus—Etoposide—sarcoma	0.000223	0.00115	CcSEcCtD
Gadoxetate—Arrhythmia—Epirubicin—sarcoma	0.000223	0.00115	CcSEcCtD
Gadoxetate—Diarrhoea—Etoposide—sarcoma	0.000216	0.00112	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—sarcoma	0.000214	0.00111	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—sarcoma	0.000214	0.00111	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—sarcoma	0.000214	0.0011	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—sarcoma	0.000212	0.0011	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—sarcoma	0.00021	0.00108	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—sarcoma	0.000209	0.00108	CcSEcCtD
Gadoxetate—Dizziness—Etoposide—sarcoma	0.000209	0.00108	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—sarcoma	0.000208	0.00108	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—sarcoma	0.000208	0.00107	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—sarcoma	0.000207	0.00107	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—sarcoma	0.000206	0.00106	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—sarcoma	0.000204	0.00106	CcSEcCtD
Gadoxetate—Ill-defined disorder—Epirubicin—sarcoma	0.000201	0.00104	CcSEcCtD
Gadoxetate—Vomiting—Etoposide—sarcoma	0.000201	0.00104	CcSEcCtD
Gadoxetate—Agitation—Epirubicin—sarcoma	0.000199	0.00103	CcSEcCtD
Gadoxetate—Rash—Etoposide—sarcoma	0.000199	0.00103	CcSEcCtD
Gadoxetate—Dermatitis—Etoposide—sarcoma	0.000199	0.00103	CcSEcCtD
Gadoxetate—Headache—Etoposide—sarcoma	0.000198	0.00102	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—sarcoma	0.000198	0.00102	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—sarcoma	0.000197	0.00102	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—sarcoma	0.000196	0.00101	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—sarcoma	0.000195	0.00101	CcSEcCtD
Gadoxetate—Syncope—Epirubicin—sarcoma	0.000195	0.00101	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—sarcoma	0.000194	0.001	CcSEcCtD
Gadoxetate—Palpitations—Epirubicin—sarcoma	0.000192	0.00099	CcSEcCtD
Gadoxetate—Loss of consciousness—Epirubicin—sarcoma	0.000191	0.000985	CcSEcCtD
Gadoxetate—Cough—Epirubicin—sarcoma	0.000189	0.000978	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—sarcoma	0.000189	0.000977	CcSEcCtD
Gadoxetate—Convulsion—Epirubicin—sarcoma	0.000188	0.000971	CcSEcCtD
Gadoxetate—Nausea—Etoposide—sarcoma	0.000188	0.000969	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—sarcoma	0.000186	0.000962	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—sarcoma	0.000185	0.000954	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—sarcoma	0.000184	0.000953	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—sarcoma	0.000184	0.000951	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000183	0.000948	CcSEcCtD
Gadoxetate—Discomfort—Epirubicin—sarcoma	0.000183	0.000943	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—sarcoma	0.000181	0.000935	CcSEcCtD
Gadoxetate—Dry mouth—Epirubicin—sarcoma	0.000181	0.000933	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—sarcoma	0.00018	0.000932	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—sarcoma	0.00018	0.00093	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—sarcoma	0.000177	0.000916	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—sarcoma	0.000177	0.000915	CcSEcCtD
Gadoxetate—Anaphylactic shock—Epirubicin—sarcoma	0.000177	0.000915	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—sarcoma	0.000176	0.000911	CcSEcCtD
Gadoxetate—Infection—Epirubicin—sarcoma	0.000176	0.000909	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—sarcoma	0.000175	0.000905	CcSEcCtD
Gadoxetate—Shock—Epirubicin—sarcoma	0.000174	0.0009	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—sarcoma	0.000174	0.000899	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—sarcoma	0.000174	0.000897	CcSEcCtD
Gadoxetate—Tachycardia—Epirubicin—sarcoma	0.000173	0.000893	CcSEcCtD
Gadoxetate—Skin disorder—Epirubicin—sarcoma	0.000172	0.000888	CcSEcCtD
Gadoxetate—Hyperhidrosis—Epirubicin—sarcoma	0.000171	0.000884	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—sarcoma	0.000171	0.000883	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—sarcoma	0.00017	0.00088	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00017	0.000877	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—sarcoma	0.000169	0.000872	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—sarcoma	0.000169	0.000872	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—sarcoma	0.000167	0.000863	CcSEcCtD
Gadoxetate—Hypotension—Epirubicin—sarcoma	0.000165	0.000855	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—sarcoma	0.000164	0.000846	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—sarcoma	0.000164	0.000846	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—sarcoma	0.000163	0.000841	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—sarcoma	0.000161	0.000833	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—sarcoma	0.000161	0.00083	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—sarcoma	0.00016	0.000826	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—sarcoma	0.000159	0.000822	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—sarcoma	0.000159	0.000821	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—sarcoma	0.000158	0.000818	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—sarcoma	0.000158	0.000816	CcSEcCtD
Gadoxetate—Anorexia—Doxorubicin—sarcoma	0.000156	0.000807	CcSEcCtD
Gadoxetate—Decreased appetite—Epirubicin—sarcoma	0.000154	0.000795	CcSEcCtD
Gadoxetate—Hypotension—Doxorubicin—sarcoma	0.000153	0.000791	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—sarcoma	0.000153	0.00079	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—sarcoma	0.000153	0.000789	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—sarcoma	0.000151	0.000782	CcSEcCtD
Gadoxetate—Paraesthesia—Doxorubicin—sarcoma	0.000147	0.00076	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—sarcoma	0.000146	0.000755	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—sarcoma	0.000146	0.000754	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Epirubicin—sarcoma	0.000145	0.000748	CcSEcCtD
Gadoxetate—Decreased appetite—Doxorubicin—sarcoma	0.000142	0.000736	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000141	0.000731	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—sarcoma	0.000141	0.00073	CcSEcCtD
Gadoxetate—Urticaria—Epirubicin—sarcoma	0.000141	0.000727	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—sarcoma	0.00014	0.000724	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—sarcoma	0.00014	0.000723	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—sarcoma	0.00014	0.000723	CcSEcCtD
Gadoxetate—Feeling abnormal—Doxorubicin—sarcoma	0.000135	0.000697	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—sarcoma	0.000134	0.000692	CcSEcCtD
Gadoxetate—Hypersensitivity—Epirubicin—sarcoma	0.00013	0.000674	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—sarcoma	0.00013	0.000672	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—sarcoma	0.00013	0.000669	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—sarcoma	0.00013	0.000669	CcSEcCtD
Gadoxetate—Asthenia—Epirubicin—sarcoma	0.000127	0.000656	CcSEcCtD
Gadoxetate—Pruritus—Epirubicin—sarcoma	0.000125	0.000647	CcSEcCtD
Gadoxetate—Diarrhoea—Epirubicin—sarcoma	0.000121	0.000626	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—sarcoma	0.000121	0.000624	CcSEcCtD
Gadoxetate—Asthenia—Doxorubicin—sarcoma	0.000118	0.000607	CcSEcCtD
Gadoxetate—Dizziness—Epirubicin—sarcoma	0.000117	0.000605	CcSEcCtD
Gadoxetate—Pruritus—Doxorubicin—sarcoma	0.000116	0.000599	CcSEcCtD
Gadoxetate—Vomiting—Epirubicin—sarcoma	0.000113	0.000582	CcSEcCtD
Gadoxetate—Diarrhoea—Doxorubicin—sarcoma	0.000112	0.000579	CcSEcCtD
Gadoxetate—Rash—Epirubicin—sarcoma	0.000112	0.000577	CcSEcCtD
Gadoxetate—Dermatitis—Epirubicin—sarcoma	0.000112	0.000576	CcSEcCtD
Gadoxetate—Headache—Epirubicin—sarcoma	0.000111	0.000573	CcSEcCtD
Gadoxetate—Dizziness—Doxorubicin—sarcoma	0.000108	0.00056	CcSEcCtD
Gadoxetate—Nausea—Epirubicin—sarcoma	0.000105	0.000543	CcSEcCtD
Gadoxetate—Vomiting—Doxorubicin—sarcoma	0.000104	0.000538	CcSEcCtD
Gadoxetate—Rash—Doxorubicin—sarcoma	0.000103	0.000534	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—sarcoma	0.000103	0.000533	CcSEcCtD
Gadoxetate—Headache—Doxorubicin—sarcoma	0.000103	0.00053	CcSEcCtD
Gadoxetate—Nausea—Doxorubicin—sarcoma	9.73e-05	0.000503	CcSEcCtD
